Ropivacaine
Ropivacaine is a long-acting amide local anesthetic used for the provision of analgesia via **perineural nerve blocks**, **regional**, and **epidural techniques**. Compared to bupivacaine, ropivacaine has a slightly faster onset of action (10-20 minutes for epidural analgesia) and is **less cardiotoxic**. It also demonstrates higher selectivity for sensory nerves over motor nerves, which decreases the degree of associated motor blockade, allowing for better mobility post-procedure. > **Clinical Warning:** Ropivacaine must never be administered intravenously or used for intravenous regional anesthesia (Bier block) due to the risk of severe, refractory cardiac arrhythmias.
Mechanism: Ropivacaine produces local anesthesia through the **reversible blockade of voltage-gated sodium channels** in nerve fibers. By binding to the intracellular portion of sodium channels, it prevents sodium influx → inhibits depolarization → prevents the generation and conduction of action potentials along the nerve fiber. Its higher lipid solubility allows it to preferentially block A-delta and C fibers (sensory/pain) over A-alpha fibers (motor).
Dosing by species
- Analgesia (perineural, epidural, or intrapleural) · Up to 4 mg/kg · Perineural/Epidural/Intrapleural · q8h · Lower doses should be used when systemic absorption is likely to be high (e.g., intrapleural). Can be diluted with normal saline for wider distribution.
- Analgesia · Maximum 2 mg/kg · Perineural/Epidural/Intrapleural · The toxic dose has not been established in cats; it is recommended not to exceed 2 mg/kg.
Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.
Routes of administration
Contraindications
- Intravenous (IV) administration
- Intravenous regional anaesthesia (Bier block)
Adverse effects
- Cardiac arrhythmias (if injected intravascularly)
- Systemic toxicity (CNS excitation followed by depression, seizures)
- Motor blockade (dose-dependent)
Drug interactions
- Other local anaesthetics · Additive systemic toxicity; dose of ropivacaine should be reduced when used in combination. · major
- Adrenaline (Epinephrine) · Unlike some other local anesthetics, the addition of adrenaline does not appear to significantly alter the duration of the ropivacaine block. · null
Monitoring
- Heart rate and rhythm (ECG)
- Blood pressure
- Signs of CNS toxicity (twitching, tremors, seizures)
- Motor function recovery
Overdose
Overdosage or inadvertent intravascular injection can lead to severe systemic toxicity. * **Cardiovascular:** May precipitate severe cardiac arrhythmias that are highly refractory to standard treatments, hypotension, and cardiovascular collapse. * **CNS:** May cause excitation, tremors, and seizures, followed by CNS depression. * **Treatment:** Supportive care, oxygen therapy, seizure control (e.g., benzodiazepines), and potentially intravenous lipid emulsion (ILE) therapy for severe toxicity.
VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.